has worked since 1990. The biomedical technology transfer program at NIH is one of the world’s largest with a portfolio that includes over 2,000 active licenses with aggregate sales greater than $10B per year that is based upon research that has also generated 44 FDA-approved drugs & vaccines.
A former chemist at the National Cancer Institute and biotech industry product manager, Mr. Ferguson holds Master’s Degrees in Business Administration (George Washington University) and Chemistry (University of Cincinnati) as well as Bachelor’s Degree in Chemistry (Case Western Reserve University).
A registered Patent Agent and a Certified Licensing Professional (CLP), Mr. Ferguson has served as faculty and Technology Transfer Department Chair at the Foundation for Advanced Education in the Sciences (FAES) Graduate School at NIH and the Biotechnology Industry Organization “BIO Boot Camp”. He also serves as a business reviewer or advisory board member for the US-India Science & Technology Endowment Fund, Maryland Industrial Partnerships, Maryland Innovation Initiative, Virginia Bio-Life Science Gap Fund, US Department of Education Small Business Innovative Research (SBIR) program, the Journal of Commercial Biotechnology and the DOD Congressionally Directed Medical Research Program.
He has published extensively in the field of technology transfer and has also received the AUTM President’s Award (AUTM Band), the AUTM Volunteer Service Award, the NIH Director’s Award, the FAES Instruction Award, five “Deal of Distinction” awards and the Frank Barnes Mentoring Award from the Licensing Executive Society, six Federal Laboratory Consortium Awards, and seventeen NIH Merit Awards in recognition of his service and activities in technology transfer.